Key result
Transaortic aortic valve implantation in high-risk or inoperable patients with severe aortic stenosis achieved a 94% device success rate and a 30-day mortality rate of 9%.
Why the study?
Does transaortic aortic valve implantation provide acceptable outcomes in patients with high-risk or inoperable aortic valve stenosis?
Observational (n=100)
No
Does transaortic aortic valve implantation provide acceptable outcomes in patients with high-risk or inoperable aortic valve stenosis?
Transaortic aortic valve implantation is a promising alternative access strategy with acceptable midterm survival for high-risk or inoperable patients with severe aortic stenosis.
Answers are grounded in this paper and cite their sources.
Supports transaortic access in high-risk aortic stenosis; hypothesis-generating, requiring randomized confirmation before practice change.
OBJECTIVE: Transaortic aortic valve implantation (TAo-AVI) through the ascending aorta is a novel technique and is used as an alternative in patients with poor femoral access. Although early results have been promising, no midterm data have been published yet. To determine whether this approach is an acceptable treatment option, we analyzed the first 100 cases performed at our institution with a follow-up to 3 years. METHODS: Between July 2011 and January 2015, a total of 100 patients with high-risk or inoperable aortic valve stenosis were treated with TAo-AVI. Preoperative patient data were collected and analyzed retrospectively. All surviving patients were seen for clinical and echocardiographic examination for follow-up. RESULTS: Median follow-up was 15 months. Device success was accomplished in 94 patients (94%). There were no access site complications. The 30-day mortality rate was 9%. Stroke occurred in a total of six patients (6%). Survival at 1-, 2-, and 3 years was 75%, 62%, and 58%, respectively. CONCLUSIONS: Our results show that TAo-AVI is a promising alternative to transapical implantation for treating severe inoperable aortic valve stenosis.
No takes yet. Share an insight, caveat, or question.
Cocchieri et al. (2016) conducted an observational in Severe aortic valve stenosis (n=100). Transaortic Aortic Valve Implantation (TAo-AVI) was evaluated on Device success. Transaortic aortic valve implantation in high-risk or inoperable patients with severe aortic stenosis achieved a 94% device success rate and a 30-day mortality rate of 9%.
Synapse has enriched 10 related papers. Consider them for comparative context: